SEC Form 4 research
| Issuer | Olema Pharmaceuticals, Inc. |
|---|---|
| Tickers | OLMA |
| Reporting owners | 46 |
| Officers and directors | 15 |
| Last public filing | 2026-09-03 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-02 | 2026-09-01 | O'Byrne Jason | A | 650,000 | $0 | Not reported |
| 2026-07-27 | 2026-07-24 | Harmon Cyrus | S | 12,500 | $11.71 | Not reported |
| 2026-07-27 | 2026-07-23 | Harmon Cyrus | S | 12,500 | $11.58 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.